Danish Biomonitor acquires Neutekbio

Biomonitor, a Danish firm that develops specialized assays to measure biopharmaceutical drug levels as well as antibodies to those drugs, has acquired the Ireland-based company Neutekbio.

Neutekbio has developed a proprietary platform and products based on reporter gene technology, as well as cell-based assays and kits called iLite, which measure the biological activity of cytokines, such as interferons and neutralizing antibodies to IFNs and TNF-alpha antagonists. These assays are essential and very important for monitoring drug activity profiles, as well as the potential immunogenicity of biopharmaceutical drugs throughout development and post-marketing.

Managing director Robert Erickson said of his firm: "Neutekbio has established product development laboratories, ISO13485-certified manufacturing facilities and has recently introduced three products to the marketplace."